Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
J Clin Psychiatry
    February 2024
  1. CITROME L, Yagoda S, Bidollari I, Wang M, et al
    Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophre
    J Clin Psychiatry. 2024;85:23m15095.
    >> Share

    January 2024
  2. MIURA I, Sano F, Sakaguchi R, Okamoto K, et al
    Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study.
    J Clin Psychiatry. 2024;85:23m14881.
    >> Share

  3. ITURRALDE E, Fazzolari L, Slama NE, Alexeeff SE, et al
    Telehealth Collaborative Care Led by Clinical Pharmacists for People With Psychosis or Bipolar Disorder: A Propensity Weighted Comparison With Usual Psychiatric Care.
    J Clin Psychiatry. 2024;85:23m14917.
    >> Share

    November 2023
  4. LONDON SM, Cawkwell PB, Shinn AK
    Medication Adherence in a Transdiagnostic First-Episode Psychosis Sample.
    J Clin Psychiatry. 2023;84:23m14947.
    >> Share

    October 2023
  5. VERGARA L, de la Serna E, Sugranyes G, Puig O, et al
    Obsessive-Compulsive Spectrum Symptoms Are Associated With Functional Impairment in Children and Adolescents With Psychosis Risk Syndrome: The CAPRIS Study.
    J Clin Psychiatry. 2023;84:22m14698.
    >> Share

    September 2023
  6. LOPENA OJ, Alphs LD, Sajatovic M, Turkoz I, et al
    Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.
    J Clin Psychiatry. 2023;84:23m14788.
    >> Share

  7. CHENG CM, Chang WH, Tsai SJ, Li CT, et al
    Risk of All-Cause and Suicide Death in Patients With Schizophrenia: An Entire-Population Longitudinal Study in Taiwan.
    J Clin Psychiatry. 2023;84:22m14747.
    >> Share

  8. CITROME L, Such P, Yildirim M, Madera-McDonough J, et al
    Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
    J Clin Psychiatry. 2023;84:23m14873.
    >> Share

    August 2023
  9. LAW C, See YM, Yee JY, Ng BT, et al
    The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14588.
    >> Share

  10. MARTINS R, Kadakia A, Williams GR, Milanovic S, et al
    The Lifetime Burden of Schizophrenia as Estimated by a Government-Centric Fiscal Analytic Framework.
    J Clin Psychiatry. 2023;84:22m14746.
    >> Share

  11. CITROME L, Meyer JM
    Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management.
    J Clin Psychiatry. 2023;84:sunscz3001sho.
    >> Share

    July 2023
  12. WESNER K, Hiemke C, Bergemann N, Egberts KM, et al
    Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy.
    J Clin Psychiatry. 2023;84:22r14626.
    >> Share

  13. ZHANG T, Xiao X, Wu H, Zeng J, et al
    Association of Attenuated Niacin Response With Inflammatory Imbalance and Prediction of Conversion to Psychosis From Clinical High-risk Stage.
    J Clin Psychiatry. 2023;84:22m14731.
    >> Share

  14. ROSSOM RC, Crain AL, Waring S, Sperl-Hillen JM, et al
    Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial.
    J Clin Psychiatry. 2023;84:22m14710.
    >> Share

    April 2023
  15. KANE JM, Mychaskiw MA, Lim S, Suett M, et al
    Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14544.
    >> Share

  16. JAIN R, Ayyagari R, Goldschmidt D, Zhou M, et al
    Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States.
    J Clin Psychiatry. 2023;84:22m14694.
    >> Share

    March 2023
  17. NASIB LG, Winter-van Rossum I, Zuithoff NPA, Boudewijns ZSRM, et al
    Generalizability of the Results of Efficacy Trials in First-Episode Schizophrenia: Comparing Outcome and Study Discontinuation of Groups of Participants in the Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial.
    J Clin Psychiatry. 2023;84:22m14531.
    >> Share

  18. KAHN RS, Kane JM, Correll CU, Arevalo C, et al
    Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study.
    J Clin Psychiatry. 2023;84:22m14674.
    >> Share

  19. IZQUIERDO A, Cabello M, Leal I, Torio I, et al
    Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study.
    J Clin Psychiatry. 2023;84:22m14401.
    >> Share

  20. CITROME L, Durgam S, Edwards JB, Davis RE, et al
    Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed.
    J Clin Psychiatry. 2023;84:22r14631.
    >> Share

  21. TAYLOR CL, Brown HK, Saunders NR, Barker LC, et al
    Preventive Health Care Among Children of Women With Schizophrenia: A Population-Based Cohort Study.
    J Clin Psychiatry. 2023;84:22m14497.
    >> Share

    February 2023
  22. RUBIO JM, Mychaskiw MA, Lim S, Suett M, et al
    Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14604.
    >> Share

  23. SABE M, Pallis K, Solmi M, Crippa A, et al
    Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis.
    J Clin Psychiatry. 2023;84:22r14490.
    >> Share

    January 2023
  24. ANDRADE C
    Prolactin-Raising and Prolactin-Sparing Antipsychotic Drugs and the Risk of Fracture and Fragility Fracture in Patients With Schizophrenia, Dementia, and Other Disorders.
    J Clin Psychiatry. 2023;84:23f14790.
    >> Share

  25. VELLIGAN DI, Rao S
    Defining and Achieving Treatment Recovery in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM6.
    >> Share

  26. VELLIGAN DI, Rao S
    Optimizing Therapy Selection, Sequencing in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM9.
    >> Share

  27. VELLIGAN DI, Rao S
    The Epidemiology and Global Burden of Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM5.
    >> Share

  28. VELLIGAN DI, Rao S
    Adverse Events and Treatment Adherence in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM8.
    >> Share

  29. VELLIGAN DI, Rao S
    Schizophrenia: Salient Symptoms and Pathophysiology.
    J Clin Psychiatry. 2023;84:MS21078COM7.
    >> Share

  30. VELLIGAN DI, Rao S
    The Emerging Treatment Landscape in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM10.
    >> Share

    December 2022
  31. AMSALEM D, Jankowski SE, Pagdon S, Valeri L, et al
    "It Is Hard to Be a Woman With Schizophrenia": Randomized Controlled Trial of a Brief Video Intervention to Reduce Public Stigma in Young Adults.
    J Clin Psychiatry. 2022;84:22m14534.
    >> Share

    November 2022
  32. NELSON EB, Franco OH, Patton BA, Schmidt LR, et al
    Telehealth of Coordinated Specialty Care in Early Psychosis During COVID-19.
    J Clin Psychiatry. 2022;84:21m14259.
    >> Share

    October 2022
  33. KADAKIA A, Catillon M, Fan Q, Williams GR, et al
    The Economic Burden of Schizophrenia in the United States.
    J Clin Psychiatry. 2022;83.
    >> Share

  34. CITROME L, Preskorn SH, Lauriello J, Krystal JH, et al
    Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
    J Clin Psychiatry. 2022;83.
    >> Share

    September 2022
  35. AHN ROBINS D, Grootendorst-van NH, Chang CK, Chandran D, et al
    Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder.
    J Clin Psychiatry. 2022;83.
    >> Share

  36. ANDRADE C
    Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

    August 2022
  37. CORRELL CU, Ismail Z, McIntyre RS, Rafeyan R, et al
    Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

  38. MISAWA F, Fujii Y, Takeuchi H
    Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
    J Clin Psychiatry. 2022;83.
    >> Share

  39. CORRELL CU, Ismail Z, McIntyre RS, Rafeyan R, et al
    Patient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

  40. LEVI L, Zamora D, Nastas I, Gonen I, et al
    Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2022;83.
    >> Share

    July 2022
  41. SCHORETSANITIS G, de Leon J
    Best Practices for Starting Clozapine in Patients With Schizophrenia: How to Switch From the Prior Antipsychotic(s).
    J Clin Psychiatry. 2022;83.
    >> Share

    June 2022
  42. CITROME L, Komaroff M, Starling B, Byreddy S, et al
    Efficacy of HP-3070, an Asenapine Transdermal System, on Symptoms of Hostility in Adults With Schizophrenia: A Post Hoc Analysis of a 6-Week Phase 3 Study.
    J Clin Psychiatry. 2022;83.
    >> Share

  43. FANG SC, Huang CY, Shao YJ
    Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

    May 2022
  44. ZHENG S, Lee J, Chan SKW
    Utility and Barriers to Clozapine Use: A Joint Study of Clinicians' Attitudes From Singapore and Hong Kong.
    J Clin Psychiatry. 2022;83.
    >> Share

  45. WEIDEN PJ, Breier A, Kavanagh S, Miller AC, et al
    Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study.
    J Clin Psychiatry. 2022;83.
    >> Share

    April 2022
  46. COHEN EA, Skubiak T, Hadzi Boskovic D, Norman K, et al
    Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

    March 2022
  47. SAWAGASHIRA R, Yamamura R, Okubo R, Hashimoto N, et al
    Subthreshold Change in Glycated Hemoglobin and Body Mass Index After the Initiation of Second-Generation Antipsychotics Among Patients With Schizophrenia or Bipolar Disorder: A Nationwide Prospective Cohort Study in Japan.
    J Clin Psychiatry. 2022;83.
    >> Share

  48. ZENG J, Raballo A, Gan R, Wu G, et al
    Antipsychotic Exposure in Clinical High Risk of Psychosis: Empirical Insights From a Large Cohort Study.
    J Clin Psychiatry. 2022;83.
    >> Share

  49. HUANG N, Wang PS, Chen CY, Bai YM, et al
    Influence of Care Delivery Models on Quality of Diabetes Care Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

  50. CORRELL CU, He Y, Therrien F, MacKenzie E, et al
    Effects of Brexpiprazole on Functioning in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.
    J Clin Psychiatry. 2022;83.
    >> Share

  51. SCHOOLER NR
    Functional Outcomes of an Antipsychotic Medication in Schizophrenia: A Generalizable or Specific Effect?
    J Clin Psychiatry. 2022;83.
    >> Share

    February 2022
  52. CORRELL CU, Abi-Dargham A, Howes O
    Emerging Treatments in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    >> Share

  53. LUI SSY, Zhang RT, Lau WYS, Liu ACY, et al
    Prospective Memory Influences Social Functioning in People With First-Episode Schizophrenia: A Network Analysis and Longitudinal Study.
    J Clin Psychiatry. 2022;83.
    >> Share

    December 2021
  54. WANG H, Zhang Y, Liu J, Chi R, et al
    Persistence With and Adherence to Paliperidone Palmitate Once-Monthly Injection for Schizophrenia Treatment in China and Japan.
    J Clin Psychiatry. 2021;83.
    >> Share

  55. WANG W, Chau AKC, Kong P, Sun X, et al
    Efficacy of Motivational Interviewing in Treating Co-occurring Psychosis and Substance Use Disorder: A Systematic Review and Meta-Analysis.
    J Clin Psychiatry. 2021;83.
    >> Share

  56. KIKKERT MJ, de Mooij L, de Koning M, Dekker J, et al
    Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample.
    J Clin Psychiatry. 2021;83.
    >> Share

  57. BEEX-OOSTERHUIS MM, Van Gool AR, Heerdink ER, van Kesteren C, et al
    Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review.
    J Clin Psychiatry. 2021;83.
    >> Share

  58. KU BS, Compton MT, Walker EF, Druss BG, et al
    Social Fragmentation and Schizophrenia: A Systematic Review.
    J Clin Psychiatry. 2021;83.
    >> Share

    November 2021
  59. RUBIO JM, Kane JM
    How to Make an Effective Offer of Clozapine.
    J Clin Psychiatry. 2021;83.
    >> Share

  60. TAKAHASHI K, Uchida H, Suzuki T, Mimura M, et al
    Comorbid Psychiatric Disorders in Patients Hospitalized for Pulmonary Embolism and Acute Myocardial Infarction: A Japanese Nationwide Database Study.
    J Clin Psychiatry. 2021;83.
    >> Share

    September 2021
  61. LE MOIGNE A, Csernansky J, Leadbetter RA, Andorn AC, et al
    PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients.
    J Clin Psychiatry. 2021;82.
    >> Share

  62. BAEZA I, de la Serna E, Amoretti S, Cuesta MJ, et al
    Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis.
    J Clin Psychiatry. 2021;82.
    >> Share

  63. CORRELL CU, Howes OD
    Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.
    J Clin Psychiatry. 2021;82.
    >> Share

  64. CHENG CM, Chen MH, Chang WH, Tsai CF, et al
    Risks of Coaggregation of Major Psychiatric Disorders Among First-Degree Relatives of Patients With Bipolar I and Bipolar II Disorder: Evidence From a Nationwide Population-Based Study.
    J Clin Psychiatry. 2021;82.
    >> Share

    August 2021
  65. OKUSAGA OO, Mitchell BG, Bernard JD, Walder A, et al
    Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2021;82.
    >> Share

    July 2021
  66. CHEN MH, Pan TL, Bai YM, Huang KL, et al
    Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study.
    J Clin Psychiatry. 2021;82.
    >> Share

  67. ZUSCHLAG ZD
    Second-Generation Antipsychotics and Suicide: A Commentary.
    J Clin Psychiatry. 2021;82.
    >> Share

  68. VERAART JKE, Smith-Apeldoorn SY, Spijker J, Kamphuis J, et al
    Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms: A Systematic Review.
    J Clin Psychiatry. 2021;82.
    >> Share

  69. BALLARD C, Aarsland D
    Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    >> Share

    June 2021
  70. STEINERT T, Jans F
    Six Cases of Perforated Appendicitis During Clozapine Treatment.
    J Clin Psychiatry. 2021;82.
    >> Share

    May 2021
  71. GRUBAUGH AL, Brown WJ, Wojtalik JA, Myers US, et al
    Meta-Analysis of the Treatment of Posttraumatic Stress Disorder in Adults With Comorbid Severe Mental Illness.
    J Clin Psychiatry. 2021;82.
    >> Share

  72. DUBREUCQ M, Plasse J, Gabayet F, Blanc O, et al
    Sex Differences in Recovery-Related Outcomes and Needs for Psychiatric Rehabilitation in People With Schizophrenia Spectrum Disorder.
    J Clin Psychiatry. 2021;82.
    >> Share

  73. SHINN AK, Carol EE
    The Importance of Context in Identifying the Recovery Needs of Women With Psychosis.
    J Clin Psychiatry. 2021;82.
    >> Share

  74. CHEN YQ, Li XR, Zhang L, Zhu WB, et al
    Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
    J Clin Psychiatry. 2021;82.
    >> Share

  75. HARVEY PD, Kane JM
    Addressing Patients' Unmet Needs to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    >> Share

    April 2021
  76. BALLARD C
    Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    >> Share

    March 2021
  77. KANE JM
    Lessening the Side Effect Burden to Improve Adherence Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2021;82.
    >> Share

  78. HARVEY PD
    Patient-Centered Treatment Strategies to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    >> Share

  79. MILLER BJ, McEvoy JP, McCall WV
    Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness.
    J Clin Psychiatry. 2021;82.
    >> Share

    February 2021
  80. BELL KS, Henderson DC, Wright HJ, Gogate JP, et al
    Treatment Effect With Paliperidone Palmitate Compared With Oral Antipsychotics in Black/African American Patients With Schizophrenia and a History of Criminal Justice System Involvement: A Post Hoc Analysis of the PRIDE Study.
    J Clin Psychiatry. 2021;82.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016